Companies: 10,795·Total market cap: $144.5T

Abeona Therapeutics Inc.

Abeona Therapeutics Inc.

ABEONASDAQHealthcare● Active

$5.38

$-0.08(-1.47%)

Market Cap$306633875

P/E Ratio—

52W High$7.54

52W Low$4

Avg Volume1.2M

Open$5.51

Beta1.35

股票排行：Biotechnology·Healthcare·查看全部市值排行 →

Abeona Therapeutics Inc.（ABEO）股票概览

关键指标与盈利、估值、营收、股息等标签页深链。

FMP · ABEO · 截至 Jun 8, 2026

关键指标

EPS (TTM)$1.28Earnings history

PE Ratio (TTM)4.2×PE Ratio deep dive

Revenue (TTM)$14.5MFull revenue history

Dividend Yield8.55%Dividend history

Shares Outstanding53.0MShares outstanding history

Next EarningsAug 13, 2026Est.Earnings history

探索 Abeona Therapeutics Inc. 数据

分析师预测$17 · Buy

盈利EPS $1.34+186.45%

财务快照

FY 2025Revenue$5.8M

202320242025

FY 2025Net Income$71.2M▲ +211.69% YoY

202320242025

FY 2025EPS$1.34▲ +186.45% YoY

202320242025

TTM:Revenue: $14.5MNet Income: $66.1MEPS: $1.28View income statement →

分析师评级与目标价

Buy9 位分析师

Strong Buy

0

Buy

6

Hold

3

Sell

0

Strong Sell

0

12-Month Price Target

$17.00Low

$5.38Current

$17.00Avg Target上涨空间 215.99%

$17.00High

合计: 9 · 买入占比: 66.7%

根据过去 3 个月内 9 位华尔街分析师，ABEO 共识评级为 Buy，12 个月平均目标价 $17.00 （较现价 $5.38 上涨空间 215.99%）。

竞争对手与同行

#TickerCompanyPriceChangeMkt Cap

Abeona Therapeutics Inc.

$5.38-1.47%$306.6M #2

Arcturus Therapeutics Holdings Inc.

$7.12-2.47%$202.4M #3

Assembly Biosciences, Inc.

$22.56-1.51%$358.5M #4

Eledon Pharmaceuticals, Inc.

$3.58+5.43%$214.6M #5

Foghorn Therapeutics Inc.

$3.71-0.54%$217.8M #6

$1.38+2.22%$231.8M

股票表现

1D-0.82%

1W-4.50%

1M-8.22%

3M+11.65%

YTD+2.75%

1Y-17.20%

5Y-87.90%

关于 Abeona Therapeutics Inc.

CEOVishwas Seshadri

IPO DateSep 19, 1980

Employees136

CountryUS

Websiteabeonatherapeutics.com

Abeona Therapeutics Inc. is a biopharmaceutical company in the clinical development stage, focused on creating innovative gene and cell therapies to address severe and uncommon genetic diseases. Its l…

Biotechnology HealthcareNASDAQUS

关于股票概览与关键数据

Abeona Therapeutics Inc.（ABEO）是 Biotechnology 行业的 Healthcare 类公司，于 Sep 19, 1980 在 NASDAQ 上市。截至最近交易日，ABEO 股价为 $5.38，市值约为 $306.6M。过去12个月累计回报 -17.20%，年初至今回报 +2.75%。

根据 9 位华尔街分析师，Abeona Therapeutics Inc. 股票共识评级为Buy，12个月平均目标价为 $17.00。2025 财年 Abeona Therapeutics Inc. 营收 $5.8M，净利润 $71.2M。更多数据（营收历史、盈利、股息、市盈率）请使用上方标签页。

常见问题

截至最近一个交易日，Abeona Therapeutics Inc.（ABEO）股价为 $5.38，在 NASDAQ 上市，52周区间为 $4.00 – $7.54。

ABEO 最新股价ABEO quote todaylive ticker 实时行情

数据来源：Financial Modeling Prep最后更新：Jun 8, 2026本内容不构成投资建议